Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 21, Number 6—June 2015
Dispatch

Oligoarthritis Caused by Borrelia bavariensis, Austria, 2014

Mateusz MarkowiczComments to Author , Stefan Ladstätter, Anna M. Schötta, Michael Reiter, Gerhard Pomberger, and Gerold Stanek
Author affiliations: Medical University of Vienna, Vienna, Austria (M. Markowicz, A.M. Schötta, M. Reiter, G. Stanek); Donauspital, Vienna (S. Ladstätter, G. Pomberger)

Main Article

Figure

Comparison of frequency of clinical manifestations in Lyme borreliosis cases between the United States and 2 countries in Europe. Data from the United States are based on 154,405 patients identified during 2001–2010 by Centers for Disease Control and Prevention surveillance (1). Cases in Europe are represented by data from southern Sweden (1,471 patients, 1992–1993) (2) and Slovenia (1,471 patients, 2000) (3). The category Lyme neuroborreliosis includes all neurologic manifestations, such as rad

Figure. Comparison of frequency of clinical manifestations in Lyme borreliosis cases between the United States and 2 countries in Europe. Data from the United States are based on 154,405 patients identified during 2001–2010 by Centers for Disease Control and Prevention surveillance (1). Cases in Europe are represented by data from southern Sweden (1,471 patients, 1992–1993) (2) and Slovenia (1,020 patients, 2000) (3). The category Lyme neuroborreliosis includes all neurologic manifestations, such as radiculoneuropathy, facial palsy, and meningitis or encephalitis. Some patients had >1 manifestation.

Main Article

References
  1. Centers for Disease Control and Prevention. Clinical manifestations of confirmed Lyme disease cases—United States, 2001–2010 [cited 2014 Dec 11]. http://www.cdc.gov/lyme/stats/chartstables/casesbysymptom.html
  2. Berglund  J, Eitrem  R, Ornstein  K, Lindberg  A, Ringér  A, Elmrud  H, An epidemiologic study of Lyme disease in southern Sweden. N Engl J Med. 1995;333:1319–27. DOIPubMedGoogle Scholar
  3. Strle  F, Stanek  G. Clinical manifestations and diagnosis of lyme borreliosis. Curr Probl Dermatol. 2009;37:51–110.PubMedGoogle Scholar
  4. Stanek  G, Wormser  GP, Gray  J, Strle  F. Lyme borreliosis. Lancet. 2012;379:461–73. DOIPubMedGoogle Scholar
  5. Huppertz  HI, Michels  H. Pattern of joint involvement in children with Lyme arthritis. Br J Rheumatol. 1996;35:1016–8. DOIPubMedGoogle Scholar
  6. Tsao  JI, Wootton  JT, Bunikis  J, Luna  MG, Fish  D, Barbour  AG. An ecological approach to preventing human infection: vaccinating wild mouse reservoirs intervenes in the Lyme disease cycle. Proc Natl Acad Sci U S A. 2004;101:18159–64. DOIPubMedGoogle Scholar
  7. Leschnik  MW, Khanakah  G, Duscher  G, Wille-Piazzai  W, Hörweg  C, Joachim  A, Species, developmental stage and infection with microbial pathogens of engorged ticks removed from dogs and questing ticks. Med Vet Entomol. 2012;26:440–6. DOIPubMedGoogle Scholar
  8. Wilhelmsson  P, Fryland  L, Börjesson  S, Nordgren  J, Bergström  S, Ernerudh  J, Prevalence and diversity of Borrelia species in ticks that have bitten humans in Sweden. J Clin Microbiol. 2010;48:4169–76. DOIPubMedGoogle Scholar
  9. Margos  G, Vollmer  SA, Cornet  M, Garnier  M, Fingerle  V, Wilske  B, A new Borrelia species defined by multilocus sequence analysis of housekeeping genes. Appl Environ Microbiol. 2009;75:5410–6. DOIPubMedGoogle Scholar
  10. Michel  H, Wilske  B, Hettche  G, Göttner  G, Heimerl  C, Reischl  U, An ospA-polymerase chain reaction/restriction fragment length polymorphism-based method for sensitive detection and reliable differentiation of all European Borrelia burgdorferi sensu lato species and OspA types. Med Microbiol Immunol. 2004;193:219–26. DOIPubMedGoogle Scholar
  11. Eiffert  H, Karsten  A, Thomssen  R, Christen  HJ. Characterization of Borrelia burgdorferi strains in Lyme arthritis. Scand J Infect Dis. 1998;30:265–8. DOIPubMedGoogle Scholar
  12. Vasiliu  V, Herzer  P, Rössler  D, Lehnert  G, Wilske  B. Heterogeneity of Borrelia burgdorferi sensu lato demonstrated by an ospA-type-specific PCR in synovial fluid from patients with Lyme arthritis. Med Microbiol Immunol. 1998;187:97–102. DOIPubMedGoogle Scholar
  13. van der Heijden  IM, Wilbrink  B, Rijpkema  SG, Schouls  LM, Heymans  PH, van Embden  JD, Detection of Borrelia burgdorferi sensu stricto by reverse line blot in the joints of Dutch patients with Lyme arthritis. Arthritis Rheum. 1999;42:1473–80. DOIPubMedGoogle Scholar
  14. Jaulhac  B, Heller  R, Limbach  FX, Hansmann  Y, Lipsker  D, Monteil  H, Direct molecular typing of Borrelia burgdorferi sensu lato species in synovial samples from patients with Lyme arthritis. J Clin Microbiol. 2000;38:1895–900.PubMedGoogle Scholar
  15. Steere  AC, Angelis  SM. Therapy for Lyme arthritis: strategies for the treatment of antibiotic-refractory arthritis. Arthritis Rheum. 2006;54:3079–86. DOIPubMedGoogle Scholar

Main Article

Page created: May 15, 2015
Page updated: May 15, 2015
Page reviewed: May 15, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external